EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service

Jeffrey Lee iD, Karen Koch iD

Australasian Journal of Dermatology · 2026-11 · 67 (7)

DOI: 10.1111/ajd.70185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australasian Journal of Dermatology, online erschienen am 24.07.2026. Verfasst von Jeffrey Lee und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Waikato Hospital, Health New Zealand Waikato, Hamilton, New Zealand. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

chronic spontaneous urticariaomalizumaburticaria control test

Autor:innen und Institutionen

  • Department of Dermatology, Waikato Hospital, Health New Zealand Waikato, Hamilton, New Zealand.
  • Auckland University, Waikato Clinical Campus, Hamilton, New Zealand.

ORCID-Profile: Jeffrey Lee, Karen Koch

Zitieren

APA

Lee, J., & Koch, K. (2026). Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service. Australasian Journal of Dermatology, 67(7). https://doi.org/10.1111/ajd.70185

Vancouver

Lee J, Koch K. Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service. Australasian Journal of Dermatology. 2026;67(7). doi:10.1111/ajd.70185

BibTeX
@article{Lee2026,
  author = {Lee, Jeffrey and Koch, Karen},
  title = {Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service},
  journal = {Australasian Journal of Dermatology},
  year = {2026},
  volume = {67},
  number = {7},
  doi = {10.1111/ajd.70185}
}
Kostenlos starten →